RNA microscope maps tumor in 3D
How cells organize themselves in a tissue is crucial to understanding how they work together – and how childhood cancer develops. Benedetta Artegiani and Delilah Hendriks are working on a new method to map tumor tissue in 3D. Not with a traditional microscope, but by analyzing the spatial information in RNA.
To understand how cells in a tissue communicate with each other, knowledge of their spatial organization is essential. 3D information can also show “islands” within a tissue of cells with different properties. This can provide insight, for example, into why a tumor only partially responds to treatment.
Research group leaders at the Princess Máxima Center, Benedetta Artegiani and Delilah Hendriks, are therefore working on a technique that uses DNA and RNA information to examine biological information of tumors directly in their 3D environment.
Thin slices
To view a tumor in 3D, researchers can use a microscope with fluorescent markers that make certain cells light up. With new technologies, for example, called spatial transcriptomics, they can look at genetic information at a deeper level. But in both methods, the tissue must first be cut into thin slices. So the tissue does not remain intact, and 3D resolution is lost – and with it, some biological information.
Spatial information without cutting
Together with an international consortium, Artegiani and Hendriks are working on a way to apply spatial transcriptomics directly to human tumor tissue in 3D. ‘We analyze the unique molecular fingerprint of each cancer cell in the tumor. This provides insight into the activity and location of each cell. But we do this with a crucial difference: without cutting up the tissue to extract the DNA and RNA from each cell,’ explains Delilah Hendriks, co-leader of the Artegiani & Hendriks group. ‘Instead, we use networks of molecular information that allow us to determine the position of each cell in our 3D model.’
Future: improving diagnosis and treatment
A research consortium led by the KTH Royal Institute of Technology in Sweden is carrying out the project, called Voluminex. The team recently received a prestigious Pathfinder Open grant, part of the European Innovation Council’s Horizon Europe program.
Artegiani and Hendriks plan to apply the technique in their research on the brain tumor organoids they developed in their group. ‘By using the spatial information in DNA, we hope to find a cost-effective way to map tumors and organoids three-dimensionally,’ said Benedetta Artegiani, co-leader of the Artegiani & Hendriks group. ‘This method can not only help study the interaction between tumor and healthy cells, but also be applied in the clinic for tumor analysis of each child. Fast, affordable 3D tumor snapshots can improve diagnosis, and possibly even lead to new treatments.’
The Voluminex consortium consists of five partners: KTH Royal Institute of Technology, the Princess Máxima Center, Karolinska Institutet, Single Technologies AB and Sorbonne University. The project received a grant of €3 million.
UMC Utrecht takes third surgical robot into use
UMC Utrecht has commissioned a third surgical robot. With the arrival of the latest generation, the Da Vinci 5, even more patients can be operated on with minimal stress. This leads to fewer complications and faster recovery. “Apart from the benefits for patients, the Da Vinci 5 also allows us to train even better,” says Jelle Ruurda, gastrointestinal surgeon and professor of robot-assisted minimally invasive surgery. “At the touch of a button, colleagues can watch remotely, and even learn from previous operations. This way we share knowledge faster and more widely.” The hospital is thus building on a tradition of 25 years at the forefront of robotic surgery.
The HU ORM program is moving to the Utrecht Science Park.
The Entrepreneurship & Retail Management (ORM) program will relocate from Amersfoort to the Utrecht Science Park as of September 1, 2026. According to program manager Lisette Luijk (Institute for Marketing & Commerce), it is mainly about one thing: more connection.
Danny Sahtoe receives NVBMB prize
Danny Sahtoe has been awarded the prestigious NVBMB prize, a prize that gives recognition to the work of a highly talented young independent researcher in the field of biochemistry or molecular biology. The prize includes funding to organize a one-day symposium on a topic of choice. Danny Sahtoe is group leader at the Hubrecht Institute and Investigator at Oncode Institute.
Inspiring and connecting visit by the President of Estonia to Utrecht Science Park
On Wednesday, April 8, 2026, the President of Estonia, Mr. Alar Karis, together with his wife Sirje Karis, ambassador Mr. Paul Teesalu and a delegation from the Estonian Health Ecosystem, visited the Utrecht Science Park. During the visit, much knowledge was exchanged and valuable connections were made.